In theory, making biopharmaceuticals 24/7—or close to it—could reduce production costs. Various models suggest switching from batch to continuous mode would cut the cost of producing almost all types ...
On a conceptual level, the benefits of “twenty-four seven” drug production are obvious. The ability to make more product, more quickly, and more efficiently will increase access to medicines and help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results